From: Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection
OR & (95% CI)
P value
Model
Change in ΔeGFR > 13 ml/min
5 (1.5 – 16.9)
0.006
Univariate
Treatment
1.2 (0.4 - 3.5)
0.736
Multivariate
1.1 (0.3 - 3.4)
0.897